Sivik Global Healthcare’s Juno Therapeutics, Inc. JUNO Stock Holding History

Sivik Global Healthcare’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,000	Closed	-$1.6M	–	77
2017 Q4	$1.6M	Sell	35,000 -20,000	-36%	-$998K	0.59%	62
2017 Q3	$2.47M	Buy	+55,000	New	+$1.88M	0.84%	46
2016 Q4	–	Sell	-35,000	Closed	-$1.05M	–	66
2016 Q3	$1.05M	Buy	+35,000	New	+$1.09M	0.53%	44
2015 Q3	–	Sell	-20,000	Closed	-$1.07M	–	70
2015 Q2	$1.07M	Hold	20,000	–	–	0.37%	63
2015 Q1	$1.21M	Buy	+20,000	New	+$971K	0.41%	69

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Sivik Global Healthcare's JUNO Position: Q1 2018 in Review

Sivik Global Healthcare sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 35,000 shares — an estimated $1.6M sold.

Sivik Global Healthcare first reported a position in JUNO in Q1 2015 and held it in 5 quarters. The position peaked at $2.47M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Sivik Global Healthcare reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Sivik Global Healthcare sold 35,000 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.6M.
Sivik Global Healthcare first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 5 quarters.
Sivik Global Healthcare's Juno Therapeutics, Inc. position peaked at $2.47M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Sivik Global Healthcare's 13F filing for Q1 2018, filed 8 May 2018.